
Keywords: فسفاتیدیلینواستول (3،4،5) تری فسفات; ACh; acetylcholine; AChE; acetylcholinesterase; AChEIs; acetylcholinesterase inhibitors; ASD; Autism Spectrum Disorder; BuChE; pseudocholinesterase; EDs; endocrine disruptors; PIP2; phosphatidylinositol (3,4)-bisphosphate; PIP3; phosphatidylinositol (3,4,